Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

“Patient engagement” is a concept that first appeared around the year 2000 in the United States and is now a growing movement in many countries, including Canada. The core idea […]

Dr. Mohit Bhandari, a member of the SAC Executive committee,  a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]

Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin Calcitonin nasal spray for the treatment of osteoporosis is no longer available in Canada because of new […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

Christine Thomas was only 42 when, bending to lift her newborn daughter, she fractured her spine. Diagnosed with five vertebral fractures as a result of unsuspected osteoporosis, she had no idea of the painful and transformative road she would have to travel to build stronger bones and reclaim her life.

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]